J Cancer 2014; 5(8):706-714. doi:10.7150/jca.9787 This issue Cite

Research Paper

Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer

Yaping Zhang1, Chengyan He2, Ling Qiu3, Yanmin Wang4, Li Zhang5, Xuzhen Qin3, Yujie Liu1, Dan Zhang1, Zhili Li1✉

1. Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, China;
2. Laboratory Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, China;
3. Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China;
4. Department of Clinical Laboratory, Heze Municipal Hospital, Heze, China;
5. Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Citation:
Zhang Y, He C, Qiu L, Wang Y, Zhang L, Qin X, Liu Y, Zhang D, Li Z. Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer. J Cancer 2014; 5(8):706-714. doi:10.7150/jca.9787. https://www.jcancer.org/v05p0706.htm
Other styles

File import instruction

Abstract

Background: Lung cancer (LC) is the deadliest cancer, with earlier stage patients having a better opportunity of long-term survival. The goal of this study is to screen less-invasive and efficient biomarkers for early detection of non-small cell LC (NSCLC).

Material and Methods: We performed the simultaneous quantitative detection of six serum unsaturated free fatty acids (FFAs, C16:1, C18:3, C18:2, C18:1, C20:4, and C22:6) from 317 healthy controls, 78 patients with benign lung diseases (BLD), and 202 patients with NSCLC using chip-based direct-infusion nanoelectrospray ionization-Fourier transform ion cyclotron resonance mass spectrometry (CBDInanoESI-FTICR MS) in the negative ion mode. Multiple point internal standard calibration curves between the concentration ratios of individual fatty acids to internal standards (ISs, C17:1 as IS of C16:1, C18:3, C18:2, and C18:1 and C21:0 as IS of C20:4 and C22:6) and their corresponding intensity ratios were constructed, with correlation coefficient of > 0.99. Mann-Whitney U test was employed to compare the differences in the levels of the FFAs between the patients and healthy controls.

Results: Significantly decreased levels of the FFAs in NSCLC patients were observed compared with healthy controls and BLD patients. Receiver operating characteristic curve analysis indicated that a combination of C16:1, C18:1, C18:3, C18:2, C20:4, and C22:6 could excellently differentiate patients with early-stage NSCLC from healthy controls plus BLD patients, with an AUC value of 0.933, a sensitivity of 84.2%, and a specificity of 89.1%. In addition, a biomarker panel (C16:1 and C18:1) was also confirmed preliminarily to monitor disease progression in NSCLC patients treated with icotinib, with a lead time between 8 and 48 weeks relative to clinical medical imaging.

Conclusion: A combination of C16:1, C18:1, C18:3, C18:2, C20:4, and C22:6 may be a powerful biomarker panel for the early detection of NSCLC and a combination of C16:1 and C18:1for disease progression monitoring of NSCLC.

Keywords: non-small cell lung cancer, biomarker panel, early detection, unsaturated free fatty acids, serum.


Citation styles

APA
Zhang, Y., He, C., Qiu, L., Wang, Y., Zhang, L., Qin, X., Liu, Y., Zhang, D., Li, Z. (2014). Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer. Journal of Cancer, 5(8), 706-714. https://doi.org/10.7150/jca.9787.

ACS
Zhang, Y.; He, C.; Qiu, L.; Wang, Y.; Zhang, L.; Qin, X.; Liu, Y.; Zhang, D.; Li, Z. Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer. J. Cancer 2014, 5 (8), 706-714. DOI: 10.7150/jca.9787.

NLM
Zhang Y, He C, Qiu L, Wang Y, Zhang L, Qin X, Liu Y, Zhang D, Li Z. Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer. J Cancer 2014; 5(8):706-714. doi:10.7150/jca.9787. https://www.jcancer.org/v05p0706.htm

CSE
Zhang Y, He C, Qiu L, Wang Y, Zhang L, Qin X, Liu Y, Zhang D, Li Z. 2014. Serum Unsaturated Free Fatty Acids: Potential Biomarkers for Early Detection and Disease Progression Monitoring of Non-Small Cell Lung Cancer. J Cancer. 5(8):706-714.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.